250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotechnology VC (Venture Capital) Funds in Sweden in September 2025

A list of 50 VC (Venture Capital) funds that invest in Biotechnology startups based in Sweden. We rank investors based on the number of investments they made in Biotechnology companies from Sweden. We update this investor list every month.

Top 50 Biotechnology VC (Venture Capital) Funds in Sweden in September 2025

Investor Biotechnology Sweden investments
Sciety 16
Chalmers Ventures AB 15
Almi Invest 11
Industrifonden 10
Navigare Ventures 6
HealthCap 5
Norrsken VC 4
Novo Holdings 4
Karolinska 4
Partnerinvest Norr 3
Crowberry Capital 3
BackingMinds 3
Voima Ventures 3
Inventure 3
Nina Capital 2
Länsförsäkringar 2
I Love Lund 2
LU Holding 2
Segulah Medical Acceleration 2
Boehringer Ingelheim Venture Fund 2
Faro Capital 2
Noaber 2
Hadean Ventures 2
SEB Venture Capital 2
EIR Ventures 2
LIU Invest 2
GOBIA Enterprises 1
Porte Monnaie 1
Investinor 1
LifeArc Ventures 1
RV Invest 1
Klimatet Invest 1
Teknoinvest 1
Plantbase Foundation 1
Inven2 1
Pär Gellerfors 1
Sting Capital 1
Norrlandsfonden 1
Social Starts 1
Impilo 1
Monesi 1
HJKK Didrikson 1
Fibonacci Growth Capital 1
PULS 1
Phase2Phase Biopharma 1
Inter Ikea 1
Irrus Investments 1
Ackra Invest 1
Flerie Invest 1
Unruly Capital 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Sciety VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in the past 12 months
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Seed, Series A, Funding Round
  • Sweden, Ukraine
Portfolio highlights
  • Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
  • PeptiSystems — PeptiSystems offers a new generation of instruments for solid-phase synthesis production of peptide and oligonucleotide therapeutics. Our instruments are used for process development and large-scale GMP and non-GMP manufacturing based on flowthrough column technology.
  • TIRmed Pharma — TIRmed Pharma develops drug candidates addressing major clinical needs.
Chalmers Ventures AB VC Fund · Göteborg, Vastra Gotaland, Sweden · 7 investments in the past 12 months
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Pre-Seed, Seed, Funding Round
  • Sweden
Portfolio highlights
  • Embedl AB — Efficient Deep Learning by Deep Learning model optimization
  • Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
  • Swedish Algae Factory — Our algae materials replace harmful and less efficient chemicals in high-end organic personal care products and has the potential of increasing the efficiency of solar panels.
Almi Invest VC Fund · Stockholm, Stockholms Lan, Sweden · 8 investments in the past 12 months
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Seed, Pre-Seed
  • Sweden, United States, United Kingdom
Portfolio highlights
  • Embedl AB — Efficient Deep Learning by Deep Learning model optimization
  • Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Industrifonden VC Fund · Stockholm, Stockholms Lan, Sweden · 7 investments in the past 12 months
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Funding Round, Series A, Seed
  • Sweden, United States, Denmark
Portfolio highlights
  • Fibbl — Fibbl is the world's first cost-effective end-to-end solution for 3D and AR focused visual marketing. Integrate 3D & AR into e-commerce and marketing in minutes.Fibbl have industrialized the process of producing photorealistic 3D models for consumer products from global brands. Fibbl has the world's largest 3D model database forconsumer products.Learn more - https://www.fibbl.com/
  • Gårdsfisk — Gårdsfisk is a company managing fishing farms. Gårdsfisks develops a new method for fish farming on land. The cultivation takes place in large pools in a closed system, where the nutrient residual water can be reused as fertilizer on the fields.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Navigare Ventures VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in the past 12 months
Welcome to Navigare Ventures. We invest in transformational early-stage companies at the frontier of science and technology.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Seed, Funding Round, Pre-Seed
  • Sweden, Denmark
Portfolio highlights
  • Repli5 — Enabling autonomous vehicles with synthetic data. We automate the creation of synthetic data and digital twins.
  • SweGaN — SweGaN's vision is to be a world leading supplier of nitride based HEMT structures. By integrating SweGaN´s technology into every single epitaxial wafer they deliver, they believe that your devices will fulfill all demands required in next generation's high power and high frequency devices.SweGaN's founders all come fromLinköping University and have more than 50 man-years experience in growth and characterization of GaN and SiC materials.SweGaN is in a highly expansive phase and they are always looking for skilled and very focused individuals with large experience in the field. If you are interested in working in a challenging and dynamic atmosphere please send us an e-mail.
  • Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in the past 12 months
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Norrsken VC VC Fund · Stockholm, Stockholms Lan, Sweden · 11 investments in the past 12 months
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more
Investment focus
  • Software, Food and Beverage, Health Care
  • Seed, Series A, Funding Round
  • Sweden, Germany, United Kingdom
Portfolio highlights
  • trawa — The partner for renewable and affordable electricity for businesses. Get electricity directly from solar and windparks with corporate PPAs.
  • Sunsave — Save money on your bills and gain energy independence with Sunsave solar panel and battery solutions. Get a free quote today.
  • Beans — Beans is on a mission to help the planet by reducing food waste, saving products, and offering them through an online grocery platform at discounted prices.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 22 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Mission Bio — We offer the only multi-omics single-cell technology solution that simultaneously detects SNV, CNV, and protein data from the same cell. Find out more.
  • Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
  • Reunion Neuroscience — Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable antidepressant for patients suffering from postpartum depressionand other mental health conditions. Reunion is also developing the RE200 series, which includes compounds with the potential for more selective serotonin receptor activity and reduced psychoactivity for application in more chronic treatment paradigms and indications.
Karolinska VC Fund · Solna, Stockholms Lan, Sweden
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Seed, Series A
  • Sweden, Denmark, United States
Portfolio highlights
  • PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
  • BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Partnerinvest Norr VC Fund · Piteå, Norrbottens Lan, Sweden · 2 investments in the past 12 months
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more
Investment focus
  • Software, Information Technology, Manufacturing
  • Seed, Funding Round, Series A
  • Sweden, United States
Portfolio highlights
  • Elastisys — We build the next generation of cloud native tech where security and privacy is the default setting.
  • Senseworks — Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
  • Cold River Games — Cold River Games is a Swedish game studio currently developing the ARPG Crystalfall.
Crowberry Capital VC Fund · Reykjavík, Gullbringusysla, Iceland · 2 investments in the past 12 months
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more
Investment focus
  • Software, Gaming, Health Care
  • Seed, Series A, Pre-Seed
  • Iceland, Denmark, Finland
Portfolio highlights
  • Tiimo — Tiimo helps you manage your daily life and improve your wellbeing. Visualize your day. Improve your routines. Stress less.
  • Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
  • Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
BackingMinds VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in the past 12 months
We help great minds unleash their full potential!
Show more
Investment focus
  • Medical Device, SaaS, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Sweden, Denmark, Finland
Portfolio highlights
  • NitroVolt — NitroVolt: the next generational step of sustainable ammonia.
  • Serviceform — Welcome to future of communication - the truly all-in-one conversion and management software built for established businesses. Start now!
  • Techarena — Since 2014 Techarena is the platform for innovation and Tech in the Nordics. From supporting startups and scaleups to bringing the Tech and Business world together at Scandinavia's Biggest Events.
Voima Ventures VC Fund · Helsinki, Southern Finland, Finland · 11 investments in the past 12 months
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
  • Biotechnology, Health Care, Artificial Intelligence
  • Seed, Pre-Seed, Funding Round
  • Finland, Sweden, Norway
Portfolio highlights
  • Farang — Farang is an AI research lab based in Sweden developing the next-generation of foundational Large Language Models. The company was founded in 2025 and consists of a team of highly experienced researchers, developers, entrepreneurs and business professionals, joined by prominent deep-tech VCs and angel investors.
  • Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
  • Agate Sensors — Agate Sensors offers equipment manufacturers advanced sensors that detect, identify, and classify people, vital signs, objects, and more. Their sensors come in a range of sizes, from single pixel devices to full matrix devices, and are produced using standard CMOS production processes, making them both cost-effective and efficient.
Inventure VC Fund · Helsinki, Southern Finland, Finland · 5 investments in the past 12 months
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • Finland, Sweden, Denmark
Portfolio highlights
  • ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
  • Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
  • Hamina Wireless — Fast and simple wireless network design and site survey tools for network engineers and IT admins - For better Wi-Fi, Private 5G, and wireless IoT. Get started in just 2 minutes!
Nina Capital VC Fund · Barcelona, Catalonia, Spain · 8 investments in the past 12 months
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Germany
Portfolio highlights
  • CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
  • EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
  • Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Länsförsäkringar VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in the past 12 months
Länsförsäkringar is a Swedish group of public insurance companies.
Show more
Investment focus
  • Real Estate, Manufacturing, Apps
  • Seed, Funding Round, Post-IPO Equity
  • Sweden
Portfolio highlights
  • Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
  • Phenaros Pharmaceuticals — Data-centric drug discovery with AI, Phenomics and Automation.
  • Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.
I Love Lund VC Fund · Lund, Skane Lan, Sweden
I Love Lund is a venture capital firm.The firm seeks opportunities to invest in pre-seed rounds
Show more
Investment focus
  • Analytics, Biotechnology, Market Research
  • Seed, Pre-Seed, Funding Round
  • Sweden
Portfolio highlights
  • Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
  • Parlametric — Parlametric is a research-based company that specializes in analytics, business intelligence, and market research services.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
LU Holding VC Fund
LU Holding is a Lund University’s investment company.
Show more
Investment focus
  • Biotechnology
  • Pre-Seed
  • Sweden
Portfolio highlights
  • Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Segulah Medical Acceleration VC Fund · Stockholm, Stockholms Lan, Sweden
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Series D, Series B
  • Sweden, Germany, United States
Portfolio highlights
  • Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
  • Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
  • Signifier Medical Technologies — Driving Innovation in the Sleep Market Signifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in the past 12 months
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
  • Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
Faro Capital VC Fund · Buenos Aires, Distrito Federal, Argentina
FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Show more
Investment focus
  • Biotechnology, Gaming, Medical
  • Series A, Seed, Funding Round
  • Sweden, United States
Portfolio highlights
  • Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
  • Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
  • IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
Noaber VC Fund · Lunteren, Gelderland, The Netherlands · 2 investments in the past 12 months
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more
Investment focus
  • Health Care, Medical, Fitness
  • Seed, Series A, Funding Round
  • The Netherlands, Israel, Sweden
Portfolio highlights
  • Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
  • Plasmacure — Plasmacure biedt het medisch apparaat PLASOMA dat bacteriedodend koud plasma direct in chronische wonden brengt met als doel wondgenezing.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Hadean Ventures VC Fund · Oslo, Oslo, Norway
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Funding Round, Series B
  • Sweden, Norway, Austria
Portfolio highlights
  • SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
SEB Venture Capital VC Fund · Stockholm, Stockholms Lan, Sweden
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more
Investment focus
  • Software, Information Technology, FinTech
  • Funding Round, Series A, Series B
  • Sweden, Denmark, United Kingdom
Portfolio highlights
  • Apica — The Operational Data Fabric from Apica unifies and connects all your data using a revolutionary Active Observability architecture.
  • ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
  • CorPower Ocean — CorPower Ocean is a turnkey supplier of wave energy systems, enabling customers to generate clean electricity from ocean waves - bringing stability to the renewable energy mix.
EIR Ventures VC Fund · Stockholm, Stockholms Lan, Sweden
EIR Ventures is a new Life Science Venture Group in the Nordics.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Seed, Funding Round
  • Denmark, Sweden, United States
Portfolio highlights
  • Henlez — Henlez is a Danish startup company.
  • ArgusEye — ArgusEye - Innovative Sensor Solutions - Real-time monitoring and control of biological systems and processes - Patented sensor technology
  • Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
LIU Invest VC Fund · Linköping, Ostergotlands Lan, Sweden
LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.
Show more
Investment focus
  • Biotechnology, Information Technology, Health Care
  • Funding Round, Seed, Pre-Seed
  • Sweden
Portfolio highlights
  • Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
  • LunaMicro — Technology company developing textile pumps based on electroosmosis and conducting polymers for a wide variety of applications including outdoor clothing, PPE, and medicine.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
GOBIA Enterprises VC Fund · Gothenburg, Vastra Gotaland, Sweden
GOBIA Enterprises is owned by Jan G Smith who has been active in the pharmaceutical industry.
Show more
Investment focus
  • Eyewear, Health Care, Health Diagnostics
  • Seed
  • Sweden
Portfolio highlights
  • Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
  • Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Porte Monnaie VC Fund
Porte Monnaie is an early and active investor for startup companies and passive investors in listed companies with growth potential. Porte-Monnaie's mission is to invest in Swedish companies.
Show more
Investment focus
  • Health Care, Biotechnology
  • Seed
  • Sweden
Portfolio highlights
  • Gedea Biotech — Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
Investinor VC Fund · Trondheim, Sor-Trondelag, Norway · 5 investments in the past 12 months
Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.
Show more
Investment focus
  • Software, Biotechnology, Manufacturing
  • Funding Round, Series A, Seed
  • Norway, United States, Sweden
Portfolio highlights
  • Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • Kongsberg Ferrotech — Kongsberg Ferrotech offers game-changing robotic services for inspection, repair, and maintenance (IRM) of underwater installations
LifeArc Ventures VC Fund · London, England, United Kingdom · 5 investments in the past 12 months
LifeArc Ventures a self-funding medical research charity that invests in Seed and Series-A stage Biotech and Healthtech companies.
Show more
Investment focus
  • Health Care, Fitness, Wellness
  • Series A, Seed
  • United Kingdom, United States
Portfolio highlights
  • GlycoEra — GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.
  • Maxion Therapeutics — Maxion Therapeutics helps in learning transformative therapies. It uses this technology to deliver long-acting, safe, and effective medications against previously inaccessible targets.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
RV Invest VC Fund · Ravensburg, Baden-Wurttemberg, Germany · 3 investments in the past 12 months
RV Invest early and stand alongside founders and researchers to bring outstanding ideas to the market.
Show more
Investment focus
  • Health Care, Therapeutics, Biotechnology
  • Series A
  • United States
Portfolio highlights
  • Akribion Genomics — Specific, versatile, effective RNA-guided cell depletion
  • Arda Therapeutics — Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA.
  • Alesta Therapeutics — Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)
Klimatet Invest VC Fund · Gothenburg, Vastra Gotaland, Sweden
Klimatet Invest is to create long-term value growth by investing relatively early in idea companies with good growth potential in cleantech and at the same time contributing to a more sustainable society.
Show more
Investment focus
  • Energy, Battery, GreenTech
  • Seed, Series A
  • Sweden
Portfolio highlights
  • Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
  • Ligna Energy — Ligna Energy is a green-tech start-up company developing disruptive technology and products for large-scale stationary electrical energy storage. The battery technology is made from cheap forest-based materials and organic polymers in combination with a water-based electrolyte. This is a unique solution foundation - enabling the world to shifttowards a fossil free energy system.
Teknoinvest VC Fund · Oslo, Oslo, Norway
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Funding Round
  • Sweden, Norway, United States
Portfolio highlights
  • GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
  • SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
  • Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
Plantbase Foundation VC Fund
Plantbase Foundation
Show more
Investment focus
  • Biotechnology, Manufacturing, Food Processing
  • Funding Round
  • Sweden
Portfolio highlights
  • Mycorena — Fungi-based, next-generation vegan protein. A food manufacturing solution superior to plants, using significantly less resources.
Inven2 VC Fund · Oslo, Oslo, Norway
Inven2 specializes in the commercialization of research and to make outstanding research into the industry of the future.
Show more
Investment focus
  • Therapeutics, Biotechnology, Pharmaceutical
  • Series A
  • Sweden
Portfolio highlights
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Pär Gellerfors VC Fund · Stockholm, Stockholms Lan, Sweden
Pär Gellerfors
Show more
Investment focus
  • Biotechnology, Medical Device
  • Funding Round
  • Sweden
Portfolio highlights
  • Sigrid Therapeutics — Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Sting Capital VC Fund · Kista, Stockholms Lan, Sweden
Sting – Stockholm Innovation & Growth enables talented people to turn their ideas into sustainable businesses. The support they offer includes qualified coaching in business development, a business angel network, a venture capital fund, a recruitment service, and an international network of investors, business contacts and experts. Itcontribute to the success of Sweden’s future technology companies by helping them to grow and compete internationally.
Show more
Investment focus
  • Software, Apps, Medical
  • Funding Round, Seed, Pre-Seed
  • Sweden
Portfolio highlights
  • Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
  • Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
  • Minnemera — Minnemera develops digital neurocognitive tests.
Norrlandsfonden VC Fund · Luleå, Norrbottens Lan, Sweden
Norrlandsfonden is a foundation that promotes the development of companies with growth ambitions. They offer flexible prime loans for new establishments, development, and expansion. They provide the opportunity for offensive and forward-looking investments and enable companies and people to grow.
Show more
Investment focus
  • Software, Information Technology, Web Hosting
  • Funding Round, Seed, Debt Financing
  • Sweden, United States
Portfolio highlights
  • Big Akwa — Big Akwa is a food-tech innovation start-up that economically and environmentally revolutionizes land-based aquaculture by introducing industrial symbiosis between the aquaculture and forest industry.
  • Flasheye — Flasheye has proven technology from the automotive, defense, and robotics industries into industrial applications.
  • Crosser — Low Code Platform, purpose-built for real-time processing of streaming data for Industrial IoT and Intelligent Workflows.
Social Starts VC Fund · San Francisco, California, United States
Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Seed, Series A, Funding Round
  • United States, Germany, United Kingdom
Portfolio highlights
  • Hey Jane — Get safe, effective and affordable abortion pills delivered fast to your home. Hey Jane is the first digital abortion clinic, connecting you to licensed providers in your state through telemedicine.
  • Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
  • Wayfinder Biosciences — We design RNA for next generation biomanufacturing and smart therapeutics.
Impilo VC Fund · Stockholm, Stockholms Lan, Sweden
Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which theyoperate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.
Show more
Investment focus
  • Biotechnology, Pharmaceutical, Medical
  • Funding Round
  • Sweden, Denmark
Portfolio highlights
  • Cavidi — Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of theworld’s leading labs.Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses.Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.
  • Scantox — Since 1977 Scantox has been a trusted partner for in-vivo preclinical research services for the pharmaceutical and medical device industries.
  • Pelago Bioscience — Pelago Bioscience offers target engagement studies of drug candidate interactions with target proteins in cells and tissues.
Monesi VC Fund
Monesi is an invesment firm.
Show more
Investment focus
  • Life Science, Biotechnology
  • Pre-Seed
  • Sweden
Portfolio highlights
HJKK Didrikson VC Fund
HJKK Didrikson operates as an investment firm.
Show more
Investment focus
  • Biopharma, Biotechnology, Pharmaceutical
  • Seed
  • Sweden
Portfolio highlights
  • AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Fibonacci Growth Capital VC Fund
Fibonacci Growth Capital is a venture capital investment firm.
Show more
Investment focus
  • Biotechnology, Manufacturing, Medical Device
  • Seed
  • Sweden
Portfolio highlights
  • Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
PULS VC Fund · Saint Charles, Illinois, United States
PULS is specialized on DIN rail power supplies for industrial applications. We set standards in terms of efficiency, reliability, size and life time.
Show more
Investment focus
  • Biopharma, Health Care, Biotechnology
  • Funding Round
  • Sweden
Portfolio highlights
  • Adenovir Pharma — Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.Adenovir Pharma was founded by researchers at the department of Virology, UmeÃ¥ University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma islocated in Helsingborg Sweden in one of Europe’s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of UmeÃ¥, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC).
Phase2Phase Biopharma VC Fund · Stockholm, Stockholms Lan, Sweden
Phase2Phase Biopharma is a consulting company that offers CMC strategies, CRO, CMO, CDMO sourcing, CMC project management, and QA services.
Show more
Investment focus
  • Biopharma, Biotechnology, Pharmaceutical
  • Seed
  • Sweden
Portfolio highlights
  • AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Inter Ikea VC Fund · Luxembourg, Luxembourg, Luxembourg
Inter IKEA Group's aim is to secure continuous improvement, development, expansion and a long life of the franchising operation.
Show more
Investment focus
  • Software, Furniture, Health Care
  • Funding Round, Seed, Corporate Round
  • Germany, Sweden, Denmark
Portfolio highlights
  • nyris — Our custom search engines make it easy for people to find products, spare parts, and components for industry and eCommerce
  • NORNORM — High quality pre-loved office furniture, including office design, installation and flexibility to change. Own less, pay less, and change whenever.
  • Seprify — Enabling sustainable products
Irrus Investments VC Fund · Limerick, Limerick, Ireland · 5 investments in the past 12 months
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more
Investment focus
  • Medical Device, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • Ireland, Sweden, United States
Portfolio highlights
  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Ackra Invest VC Fund · Skellefteå, Vasterbottens Lan, Sweden
Ackra Invest AB is a venture capital and private equity firm specializing in late venture, growth capital and turnaround investments. The firm does not have a sector preference and seeks to invest in small and middle sized companies based in Norrland; the Northern region of Sweden. It does not provide loans or invest in seed or early venture. Thefirm takes minority stakes, between 10 percent and 49 percent and invests between SEK1 million ($0.13 million) and SEK8 million ($1.02 million). It invests in equity or convertible loans and can perform co-investments. The firm seeks to exit its investments within seven years. Ackra Invest AB was founded in 2005 and is based in Skellefteå, Sweden.
Show more
Investment focus
  • Manufacturing, Mining, Chemical
  • Funding Round, Seed
  • Sweden
Portfolio highlights
  • Xore — Xore AB has develops and sells analyzers to enrichment plants in the mining industry.Xore is one of the world’s leading suppliers of on-stream analyzers and related services to the mining industry. Xore is the natural first choice when investing in equipment for on-stream analysis of pulp and liquids. Our product brand is Boxray™. Xore is agenuine Swedish engineering technology company based in Skellefteå in northern Sweden.
  • Protab AB — Protab specializes in machining, turning and milling and manufactures details for the hydraulic and forest industry. Another important part of the business is system delivery, where the company also assembles the details that were manufactured.Protab manufactures components primarily for the hydraulics and forestry industries. System deliveries,where the company assembles manufactured components, form another important part of the operation. We also do value flow analyses to improve the efficiency of our customers' businesses. How can we make things better for you?
  • Fortlax AB — Fortlax is Northern Sweden's data center with three world-class facilities just outside Piteå. We help companies grow using smart IT and cloud services. We store data in highest-class facilities at a location where risk analysis shows extremely low risk of natural disasters. In addition, we operate all our facilities with 100% green energy anduse natural cooling for large parts of the year. Fortlax AB has over the past fiscal year more than tripled its revenue and shows profit.
Flerie Invest VC Fund · 2 investments in the past 12 months
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Sweden, Israel, Iceland
Portfolio highlights
  • Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
  • Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
  • Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Unruly Capital VC Fund · Italy, Texas, United States · 3 investments in the past 12 months
Investing in the crazy before it becomes normal
Show more
Investment focus
  • Biotechnology, CleanTech, Manufacturing
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, United States, Germany
Portfolio highlights
  • Ephos — Designing and manufacturing glass-based integrated photonic circuits that power the most advanced classical and quantum devices
  • AtmoCooling — AtmoCooling transforms coastal deserts into thriving hubs of agriculture, clean energy, and climate resilience. It was founded in 2022 and operates in the USA and UAE.
  • Terran Robotics — Terran Robotics is a construction company that specializes in AI and robotics. The company's headquarters are in Bloomington, Indiana.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Sweden by industry